These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23531480)

  • 1. Thrombin generation and microparticles in inflammatory bowel diseases.
    Stadnicki A
    J Pediatr Gastroenterol Nutr; 2013 Apr; 56(4):343. PubMed ID: 23531480
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased procoagulant function of microparticles in pediatric inflammatory bowel disease: role in increased thrombin generation.
    Deutschmann A; Schlagenhauf A; Leschnik B; Hoffmann KM; Hauer A; Muntean W
    J Pediatr Gastroenterol Nutr; 2013 Apr; 56(4):401-7. PubMed ID: 23164759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procoagulant activity, but not number, of microparticles increases with age and in individuals after a single venous thromboembolism.
    Owen BA; Xue A; Heit JA; Owen WG
    Thromb Res; 2011 Jan; 127(1):39-46. PubMed ID: 21106230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue factor-bearing microparticles and inflammation: a potential mechanism for the development of venous thromboembolism in cancer.
    Date K; Ettelaie C; Maraveyas A
    J Thromb Haemost; 2017 Dec; 15(12):2289-2299. PubMed ID: 29028284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microparticles in vascular disorders: how tissue factor-exposing vesicles contribute to pathology and physiology.
    Kleinjan A; Böing AN; Sturk A; Nieuwland R
    Thromb Res; 2012 Oct; 130 Suppl 1():S71-3. PubMed ID: 23026670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of hypercoagulable state after blunt trauma: microparticle and thrombin generation are increased relative to injury severity, while standard markers are not.
    Park MS; Owen BA; Ballinger BA; Sarr MG; Schiller HJ; Zietlow SP; Jenkins DH; Ereth MH; Owen WG; Heit JA
    Surgery; 2012 Jun; 151(6):831-6. PubMed ID: 22316436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue factor exposing microparticles in inflammatory bowel disease.
    Palkovits J; Novacek G; Kollars M; Hron G; Osterode W; Quehenberger P; Kyrle PA; Vogelsang H; Reinisch W; Papay P; Weltermann A
    J Crohns Colitis; 2013 Apr; 7(3):222-9. PubMed ID: 22705067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strenuous exercise promotes shear-induced thrombin generation by increasing the shedding of procoagulant microparticles from platelets.
    Chen YW; Chen JK; Wang JS
    Thromb Haemost; 2010 Aug; 104(2):293-301. PubMed ID: 20589321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microparticles: a link to increased thrombin generation.
    Gasa N; Meiring M
    Blood Coagul Fibrinolysis; 2021 Apr; 32(3):204-208. PubMed ID: 33560006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
    Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
    Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microparticles and cancer thrombosis in animal models.
    Mege D; Mezouar S; Dignat-George F; Panicot-Dubois L; Dubois C
    Thromb Res; 2016 Apr; 140 Suppl 1():S21-6. PubMed ID: 27067974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of tissue factor positive microparticles.
    Key NS
    Thromb Res; 2010 Apr; 125 Suppl 1(Suppl 1):S42-5. PubMed ID: 20189224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of venous thromboembolism with inflammatory bowel disease.
    Saleh T; Matta F; Yaekoub AY; Danescu S; Stein PD
    Clin Appl Thromb Hemost; 2011 Jun; 17(3):254-8. PubMed ID: 20211927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles.
    Gerotziafas GT; Van Dreden P; Chaari M; Galea V; Khaterchi A; Lionnet F; Stankovic-Stojanovic K; Blanc-Brude O; Woodhams B; Maier-Redelsperger M; Girot R; Hatmi M; Elalamy I
    Thromb Haemost; 2012 Jun; 107(6):1044-52. PubMed ID: 22535498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Microparticles and Coagulation Profiles in Patients with Advanced Stage Solid Tumors.
    Sun S; Lee HK; Kim Y; Lee JH; Won HS; Ko YH; Kim H
    Ann Lab Med; 2018 May; 38(3):274-276. PubMed ID: 29401565
    [No Abstract]   [Full Text] [Related]  

  • 16. Protein S and factor V in regulation of coagulation on platelet microparticles by activated protein C.
    Somajo S; Koshiar RL; Norström E; Dahlbäck B
    Thromb Res; 2014 Jul; 134(1):144-52. PubMed ID: 24835672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue factor microparticles and haemophilia.
    Gross PL; Vaezzadeh N
    Thromb Res; 2010 Apr; 125 Suppl 1():S67-9. PubMed ID: 20171716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microparticles expressing tissue factor are concurrently released with markers of inflammation and coagulation during human endotoxemia.
    Woei-A-Jin FJ; De Kruif MD; Garcia Rodriguez P; Osanto S; Bertina RM
    J Thromb Haemost; 2012 Jun; 10(6):1185-8. PubMed ID: 22489893
    [No Abstract]   [Full Text] [Related]  

  • 19. Procoagulant effects of lung cancer chemotherapy: impact on microparticles and cell-free DNA.
    Lysov Z; Dwivedi DJ; Gould TJ; Liaw PC
    Blood Coagul Fibrinolysis; 2017 Jan; 28(1):72-82. PubMed ID: 26919453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The multisystem impact on physiologic processes of inflammatory bowel disease.
    Lewicki LJ; Leeson MJ
    Nurs Clin North Am; 1984 Mar; 19(1):71-80. PubMed ID: 6560537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.